Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) Launches Second Stage of Manufacturing of Ibogaine for Clinical Research
The company has filed patent applications for two routes of chemical synthesis of ibogaine – offering potential advantages of improved…